SYNTHESIS OF POLYPROPIONATE DERIVED NATURAL PRODUCTS

聚丙酸酯衍生天然产物的合成

基本信息

项目摘要

DESCRIPTION: (Principal Investigator's) This research proposal reflects our general interest in the development of new reagents in the context of acyclic stereocontrol. Once the reaction methodology has achieved success in the development stage, it is used in the asymmetric synthesis of complex organic molecules that may have relevance in the treatment of human diseases. The long term objectives are the eventual achievement of the asymmetric synthesis of th macrolide antibiotics, rutamycin B, oligomycin C, oleanolide, discodermolide, and the proteosome inhibitor lactacystin. In this regard, we intend to 1. explore the scope of double stereodifferentiating reactions of chiral allylsilane reagents with chiral aldehyde partners. This study will be used to determine their potential utility for polypropionate assemblage as well as vicinal amino alcohols. As a new direction for this technology we will develop novel approaches to the synthesis of new allylsilane reagents bearing C-centered chirality; allylsilanes and beta-substituted (E)-crotylsilanes. These approaches include the development of chiral Lewis acids to promote asymmetric (2,3) and (3,3)-sigmatropic processes. 2. Pursue the completion of the synthesis of polypropionate derived macrolide antibiotics, rutamycin B and oligomycin C. 3. Pursue the total synthesis of the macrolide antibiotic oleanolide. 4. Pursue the total synthesis of the microtubule stabilizing agent discodermolide. 5. Pursue the total synthesis of unusual amino acid (+)-lactacystin.
描述:(首席研究员)本研究计划反映了我们的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES S. PANEK其他文献

JAMES S. PANEK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES S. PANEK', 18)}}的其他基金

SYNTHESIS OF POLYPROPIONATE DERIVED NATURAL PRODUCTS
聚丙酸酯衍生天然产物的合成
  • 批准号:
    2608980
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
SYNTHESIS OF POLYPROPIONATE DERIVED NATURAL PRODUCTS
聚丙酸酯衍生天然产物的合成
  • 批准号:
    6181163
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
Synthesis of Polyprionate Derived Natural Products
聚丙酸衍生天然产物的合成
  • 批准号:
    7093609
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
Synthesis of Polyprionate Derived Natural Products
聚丙酸衍生天然产物的合成
  • 批准号:
    7246463
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
Synthesis of Polyprionate Derived Natural Products
聚丙酸衍生天然产物的合成
  • 批准号:
    6922931
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
Synthesis of Polyprionate Derived Natural Products
聚丙酸衍生天然产物的合成
  • 批准号:
    6824161
  • 财政年份:
    1998
  • 资助金额:
    $ 17.26万
  • 项目类别:
ASYMMETRIC SYNTHESIS OF ANTITUMOR AGENTS
抗肿瘤剂的不对称合成
  • 批准号:
    2501135
  • 财政年份:
    1994
  • 资助金额:
    $ 17.26万
  • 项目类别:
Asymmetric Synthesis of Antitumor Agents
抗肿瘤药物的不对称合成
  • 批准号:
    6737525
  • 财政年份:
    1994
  • 资助金额:
    $ 17.26万
  • 项目类别:
ASYMMETRIC SYNTHESIS OF ANTITUMOR AGENTS
抗肿瘤剂的不对称合成
  • 批准号:
    2097239
  • 财政年份:
    1994
  • 资助金额:
    $ 17.26万
  • 项目类别:
Asymmetric Synthesis of Antitumor Agents
抗肿瘤药物的不对称合成
  • 批准号:
    7049557
  • 财政年份:
    1994
  • 资助金额:
    $ 17.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了